Main

Fields of interest:

• Autonomic Neuroscience
• Purinergic Signalling

Recent publications:

G. Burnstock:
Purinergic P2 receptors as targets for novel analgesics.
Pharmacol. Therap., Vol. 110, 2006, pp. 433-454.

G. Burnstock:
Purinergic signalling and vascular tone and remodeling.
Nature Medicine – News and Views, Vol. 12, 2006, pp. 16-17.

G. Burnstock:
Historical Review: ATP as a neurotransmitter.
Trends in Pharmacological Sciences, Vol. 27, 2006, pp. 166-176.

G. Burnstock:
Pathophysiology and therapeutic potential of purinergic signalling.
Pharmacological Reviews, Vol. 58, 2006, pp. 58-86.

N. White and G. Burnstock:
P2 receptors and cancer.
Trends in Pharmacological Sciences, Vol. 27, 2006, pp. 211-217.

F. Banks, G. Knight, R.C. Calvert, C.S. Thompson, D.P. Mikhailidis, R. Morgan and G. Burnstock:
The purinergic component of human vas deferens contraction.
Fertility and Sterility, Vol. 85, 2006, pp. 932-939.

J. Gever, D.A. Cockayne, M.P. Dillon, G. Burnstock and A.P.D.W. Ford:
Pharmacology of P2X channels.
Pflugers Arch, Vol. 452, 2006, pp. 513-537.

D. Fields and G. Burnstock:
Purinergic signaling in neuron-glial interactions. Nature Neuroscience Reviews, Vol. 7, 2006, pp. 423-436.

M.P. Abbracchio, G. Burnstock, J.-M. Boeynaems, E.A. Barnard, J.L. Boyer, C. Kennedy, G.E. Knight, M. Fumagalli, C. Gachet, K.A. Jacobson and G.A. Weisman:
International Union of Pharmacology. Update and subclassification of the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy.
Pharmacological Reviews, Vol. 58, 2006, pp. 1-61.

G. Burnstock and T.R. Arnett:
Nucleotides and Regulation of Bone Cell Function.
Taylor & Francis Group, Boca Raton, Florida, 2006, pp. 1-207.